Competence Centre for Transcultural Psychiatry Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT02761161
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Competence Centre for Transcultural Psychiatry

Active Ingredients

Drugs in Phase 4 Trials (1)

mianserin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyssomnias (Phase 4)

Parasomnias (Phase 4)

Sleep Wake Disorders (Phase 4)

Stress Disorders, Post-Traumatic (Phase 4)

Stress Disorders, Traumatic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1